Coverage of Prescribed Drugs during a Drug Shortage
The Oklahoma Health Care Authority will seek approval of a policy amendment to address special circumstances arising from drug shortages to mitigate the effects of shortages and to ensure continued access to medication. A shortage must be identified by the Food and Drug Administration (FDA), or the American Society of Health-System Pharmacists (ASHP) for non-covered outpatient drugs to be covered when medically necessary during a drug shortage. This includes imported drugs authorized for temporary import by the FDA. Reimbursement for drugs covered during a drug shortage will be according to existing payment methodology for covered outpatient drugs and will be subject to the same requirements and limitations, such as prior authorization.
Please view the draft SPA here: OK SPA #24-0018
Interested parties may submit feedback via the comment box.
Circulation Date: June 21, 2024
Tribal Consultation Period: June 21 – August 20, 2024
Comment Due Date: July 21, 2024
SPA Effective Date: August 1, 2024; Contingent upon CMS approval
Submit a Comment
After you submit your comment, you should be re-directed to a confirmation page. If you are not, please submit your comment through e-mail to federal.authorities@okhca.org.
Please note that all comments must be reviewed and approved prior to posting. Approved comments will be posted Monday through Friday between the hours of 7:30 a.m. – 4 p.m. Any comments received after 4 p.m. will be posted on the following business day.
Comments
No comments.
